Celgene Revenue and Competitors

Summit, NJ USA

Location

$103.5M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Celgene's total funding is $103.5M.

Employee Data

  • Celgene has 2734 Employees.(i)
  • Celgene grew their employee count by -13% last year.

Celgene's People

NameTitleEmail/Phone
1
CEO, Celgene Global Health and CMO, Celgene CorporationReveal Email/Phone
2
Head Mobile and Corporate WebsitesReveal Email/Phone
3
Head, Clinical Reseach and Development I&IReveal Email/Phone
4
Associate Director, External ManufacturingReveal Email/Phone
5
Associate Director Technical OperationsReveal Email/Phone
6
DirectorReveal Email/Phone
7
Assoc. Director, Cell Therapy External Manufacturing & Strategic Sourcing, CelgeneReveal Email/Phone
8
Director, Head EHSReveal Email/Phone
9
Senior Director, Global Commercialization, MyeloidReveal Email/Phone
10
Associate Director External API QA OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Celgene?

Celgene Corporation, headquartered in Warren, New Jersey, is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.

keywords:N/A

$103.5M

Total Funding

2734

Number of Employees

N/A

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Celgene News

2022-04-20 - Thalassemia Market Size, Outlook And Forecast | Bluebird bio ...

Bluebird bio, Acceleron Pharma, Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, Kiadis Pharma,...

2022-04-20 - Myeloproliferative Disorders Drugs Market Size, Outlook And ...

Celgene, Bristol-Myers Squibb, Gamida Cell, Incyte, Geron, Promedior, Johnson & Johnson. This comprehensive Myeloproliferative Disorders...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$849.8M42282%N/A